BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 149422)

  • 21. [Complex compounds of heparin with blood proteins and their natural inhibitors in splenectomy in animals].
    Liapina LA; Kondashevskaia MV; Azieva LD; Soboleva GI
    Patol Fiziol Eksp Ter; 1990; (4):20-2. PubMed ID: 2080078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The origin and physiological importance of activated plasminogen and plasmin in excitation of the anticoagulative system].
    Kudriashov BA; Liapina LA
    Vopr Med Khim; 1973; 19(2):136-40. PubMed ID: 4267634
    [No Abstract]   [Full Text] [Related]  

  • 23. [Fibrinolytic system of animals repeatedly and chronically administered plasminogen tissue activator].
    Shimonaeva EE; Liutova LV; Andreenko GV
    Vopr Med Khim; 1981; 27(6):823-8. PubMed ID: 7199779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of intermediate products of prothrombin proteolysis by thrombin in the stimulation of the anticoagulation system of blood].
    Kudriashov BA; Strukova SM; Orlova AS; Liapina LA
    Biull Eksp Biol Med; 1976 Oct; 82(10):1172-4. PubMed ID: 1029494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
    Schwartz LB; Bradford TR; Littman BH; Wintroub BU
    J Immunol; 1985 Oct; 135(4):2762-7. PubMed ID: 3161948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Complex compounds of plasminogen with heparin (PGH) and plasmin with heparin (PH) and their importance in regulating the liquid state of the blood].
    Kudriashov BA; Liapina LA
    Probl Gematol Pereliv Krovi; 1972 Apr; 17(4):28-30. PubMed ID: 4282511
    [No Abstract]   [Full Text] [Related]  

  • 27. [Formation of a secondary adrenaline-heparin-fibrinogen complex and its properties].
    Kudriashov BA; Liapina LA; Zhitnikova ES; Obraztsov VV
    Vopr Med Khim; 1975; 21(1):65-9. PubMed ID: 1119113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of the inhibitors of fibrinolysis in human, dog and rabbit blood.
    Gallimore MJ; Nulkar MV; Shaw JT
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):145-58. PubMed ID: 16955972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of proteinase inhibitors, plasminogen antiactivators, heparin and acetylsalicylic acid on the experimental disseminated intravascular coagulation induced by thormbin.
    Moriau M; Rodhain J; Noel H; Beys-Col CD; Masure R
    Thromb Diath Haemorrh; 1974 Sep; 32(1):171-88. PubMed ID: 4281540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glomerular fibrinolytic activity after thrombin perfusion in the rat.
    Sraer JD; Delarue F; Dard S; De Seigneux R; Morel-Maroger L; Kanfer A
    Lab Invest; 1975 Apr; 32(4):515-7. PubMed ID: 123973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thrombotic complications in the blocking effect of protamine sulfate on nonenzymatic fibrinolysis in the blood of animals during activation of the anticoagulation system].
    Liapina LA; Kudriashov BA
    Vopr Med Khim; 1979; 25(2):209-14. PubMed ID: 442592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrinolytic treatment by infusion of streptokinase-plasminogen-complex (activator): laboratory effects.
    Martin H; Auel H; Riedel C
    Behring Inst Mitt; 1986 Feb; (79):263-71. PubMed ID: 2424424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Activation of the anticoagulant system by prethrombin 2, a thrombin precursor].
    Strukova SM; Umarova BA; Gribkova NN; Kudriashov BA
    Biull Eksp Biol Med; 1980 Mar; 89(3):270-2. PubMed ID: 6966943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass.
    Tabuchi N; de Haan J; Boonstra PW; van Oeveren W
    J Thorac Cardiovasc Surg; 1993 Nov; 106(5):828-33. PubMed ID: 8231204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Activation of the fibrinolytic system following subcutaneous administration and inhalation of heparin].
    Psuja P; Tokarz A; Turowiecka Z; Sowier J; Zawilska K
    Pol Tyg Lek; 1993 Feb 1-8; 48(5-6):105-8. PubMed ID: 8361902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Significance of a relative excess of vitamin A and unsaturated fatty acids in the formation of complex heparin compounds under stress in animals maintained on natural and atherogenic rations].
    Kudriashov BA; Bazaz'ian GG; Liapina LA; Sytina NP
    Vopr Pitan; 1973; 32(1):23-9. PubMed ID: 4273549
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of complexes of heparin with plasma proteins on the anticoagulant and fibrinolytic activity of blood].
    Kudriashov BA; Pastorova VE; Liapina LA
    Fiziol Zh SSSR Im I M Sechenova; 1986 Dec; 72(12):1653-8. PubMed ID: 3817209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of the antithrombin III-heparin-thrombin complex in the defense reaction of the anticoagulation system].
    Kudriashov BA; Liapina LA; Pastorova VE
    Vopr Med Khim; 1988; 34(2):38-42. PubMed ID: 3400189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amidolytic activity of plasma euglobulins.
    Jasielczuk J; Dabrowka M; Gacko M; Jankiewicz M
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():250-1. PubMed ID: 15638440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.